Finally It's Out! What the NICE Position on the AI Use in Evidence Generation and Synthesis Means for HTA Submissions – the Do’s and Don’ts
Speaker(s)
Grammati Sarri, PhD, MSc, DiDS, Cytel, London, UK, Sophia van Beekhuizen, MSc, MPhil, Cytel, Rotterdam, Netherlands and Grace Hsu, MSc, Cytel, Waltham, MA, USA
Presentation Documents
The moderator will introduce the main points in the NICE AI statement and present some background HEOR research that may have mobilized the agency to publish such statement. The other panelists will present specific opportunities and challenges in translating the NICE position on AI during conducting systematic literature reviews, comparative clinical and cost-effectiveness analysis and using RWE in data analytics. Finally, the moderator will close by presenting a roadmap (checklist) to be used when AI tools are considered in NICE submissions and will open the floor for discussion with the audience.
Sponsor: Cytel
Code
309
Topic
Medical Technologies